Hosted on MSN3h
RBC Capital Downgrades Intra-Cellular Therapies (ITCI)
Fintel reports that on January 22, 2025, RBC Capital downgraded their outlook for Intra-Cellular Therapies (NasdaqGS:ITCI) ...
Globe Life: A Stalwart That Can Balance Growth And Profitability
Globe Life demonstrates steady EPS growth due to disciplined underwriting and cost efficiency. Read more to see why I'm a ...
RBC Capital Sticks to Their Buy Rating for Osisko Gold Royalties (OR)
In a report released on January 20, Josh Wolfson from RBC Capital maintained a Buy rating on Osisko Gold Royalties (OR – Research Report), with ...
RBC maintains Outperform rating on Shopify stock with $130 target
RBC Capital Markets maintained its Outperform rating on Shopify (NYSE:SHOP) with a steadfast price target of $130.00, positioning it between the analyst range of $78 to $145. RBC Capital's analysis ...
BOK Financial price target raised to $120 from $115 at RBC Capital
RBC Capital raised the firm’s price target on BOK Financial (BOKF) to $120 from $115 and keeps a Sector Perform rating on the shares after its ...
RBC CEO McKay on US Relationship, AI Power, Net Zero
RBC Chief Executive Officer Dave McKay discusses the long-term relationship between Canada and the United States, uncertainty in Canadian government, and taking advantage of AI opportunities and ...